Following its announcement to support the reopening of medical aesthetic clinics, the Joint Council for Cosmetic Practitioners (JCCP) has further clarified what it considers to be an appropriate premises or clinic to deliver medically-related aesthetic treatments.
The Committees of Advertising Practice (CAP) has issued an Enforcement Notice following recent reports of education providers not adhering to its advertising rules for promoting training for injectable procedures.
Government-approved register of accredited practitioners, Save Face, has recieved 80 complaints of private procedures being promoted on social media, despite current government guidelines to social distance.
After days of speculation, the Medicines and Healthcare Products Regulatory Agency (MHRA) has confirmed that it has no plans in place to make dermal fillers prescription only.
Today the chair of the Joint Council for Cosmetic Practitioners (JCCP) Professor David Sines and aesthetic nurse prescriber Sue Ibrahim took part in a debate regarding the regulation in the aesthetics specialty on the BBC Radio 4’s consumer affairs programme You & Yours.
The regulator for independent healthcare services in Scotland, Healthcare Improvement Scotland (HIS), has published an updated version of its Enforcement Policy which it will follow when using its enforcement powers.
A statement by the Association for Cosmetic Practitioners Britain (ACPB) has been released today in response to the recent Joint Council for Cosmetic Practitioners' (JCCP) announcement to only allow healthcare professionals onto Part 1 of the JCCP Practitioner Register.
The Joint Council for Cosmetic Practitioners (JCCP) has released a statement clarifying its stance on practitioners offering treatments that currently fall outside the remit of the body.
The British Association of Aesthetic Plastic Surgeons (BAAPS) has issued a statement supporting a petition to make it illegal for practitioners to offer cosmetic surgery without appropriate insurance.
New technology will be in place from January 31 to monitor advertisements on social media relating to the promotion of prescription-only medicines (POMs) such as botulinum toxin.